ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Anavex Life Sciences Corporation

Anavex Life Sciences Corporation (AVXL)

9.09
0.06
(0.66%)
9.15
0.06
(0.66%)

Anavex Life Sciences Corporation Financial Summary

The current AVXL market cap is 781.15M. The company's latest EPS is USD -0.5037 and P/E is -18.01.

Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -12.52M-14.73M-14.34M-13.59M-12.51M
Net Income -10.55M-12.21M-11.62M-12.11M-11.2M
Year End September 29 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 054k000
Operating Income -31.09M-41.95M-50.99M-55.76M-52.88M
Net Income -26.28M-37.91M-47.98M-47.51M-43M
Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 144.52M141.54M135.57M124.04M117.14M
Total Liabilities 9.56M11.75M15.3M13.13M17.38M
Total Equity 134.96M129.78M120.26M110.92M99.76M
Year End September 29 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 34.54M161.62M152.71M154.39M135.57M
Total Liabilities 7.31M10.8M10.21M12.53M15.3M
Total Equity 27.24M150.82M142.49M141.85M120.26M
Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -18.97M-24.15M-30.81M-12.12M-17.98M
Investing N/A N/A N/A N/A N/A
Financing 7.34M11.89M11.98M708k1.56M
Year End September 29 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -21.29M-30.38M-24.24M-27.79M-30.81M
Investing N/A N/A N/A N/A N/A
Financing 28.35M153.24M21.29M29.65M11.98M
Market Cap 781.15M
Price to Earnings Ratio -18.01
Price to Sales Ratio 0
Price to Cash Ratio 5.86
Price to Book Ratio 6.44
Dividend Yield -

Share Statistics

Shares Outstanding 85.37M
Average Volume (1 week) 734.63k
Average Volume (1 Month) 778.08k
52 Week Change 137.66%
52 Week High 14.4405
52 Week Low 3.76
Spread (Intraday) 0.65 (7.03%)

Company Info

Company Name Anavex Life Sciences Corporation
Address 701 s carson st
carson city, nevada 89701
Website https://www.anavex.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock